The effect of the interaction of pyrazinamide and probenecid on urinary uric acid excretion in man.
Complex interactions occur between pyrazinamide (PZA) and probenecid in man involving both the metabolism and distribution of the drugs, and their effects on renal tubules. Pretreatment with PZA prolonged the half-life (T 1/2) of probenecid without changing its plasma-binding. As the rate of probenecid metabolism is decreased, its uricosuric action tends to be prolonged and the effect of PZA lessened. The PZA-suppressible urate level is increased to values well above control after the administration of probenecid; it is less after alkalinization of urine, although still larger than the value for PZA-suppressible urate after the administration of PZA alone. Urinary probenecid excretion is much greater when urine is alkalinized. These observed drug interactions, plus the known effect of probenecid to block secretion of PZA, have to be considered in evaluating the effect of the two drugs given together, compared to the effect of each drug given separately.
D000328:Adult; D000368:Aged; D004347:Drug Interactions; D006207:Half-Life; D006801:Humans; D007684:Kidney Tubules / Q000187:drug effects / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D011339:Probenecid / Q000097:blood / Q000494:pharmacology* / Q000652:urine; D011718:Pyrazinamide / Q000494:pharmacology*; D014527:Uric Acid / Q000652:urine*
D014527:Uric Acid; D011718:Pyrazinamide; D011339:Probenecid